General Information of the Compound
Compound ID |
CP0399869
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
2-{2-[2-[2-Acetylamino-3-(3H-imidazol-4-yl)-propionylamino]-3-(1H-indol-3-yl)-propionylamino]-propionylamino}-N-{[1-(1-butyl-pentylcarbamoyl)-2-(3H-imidazol-4-yl)-ethylcarbamoyl]-methyl}-3-methyl-butyramide
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C44H64N12O7
|
||||||||||||||||||
Molecular Weight |
873.073
|
||||||||||||||||||
Canonical SMILES |
CCCCC(CCCC)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(C)=O)C(C)C
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C44H64N12O7/c1-7-9-13-30(14-10-8-2)53-42(61)37(19-32-22-46-25-50-32)54-38(58)23-48-44(63)39(26(3)4)56-40(59)27(5)51-41(60)35(17-29-20-47-34-16-12-11-15-33(29)34)55-43(62)36(52-28(6)57)18-31-21-45-24-49-31/h11-12,15-16,20-22,24-27,30,35-37,39,47H,7-10,13-14,17-19,23H2,1-6H3,(H,45,49)(H,46,50)(H,48,63)(H,51,60)(H,52,57)(H,53,61)(H,54,58)(H,55,62)(H,56,59)/t27-,35-,36-,37-,39-/m0/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
ZRLBFYYYALPPHU-QFJONTTISA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound